Stevens Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,237
Closed -$54K 1172
2014
Q3
$54K Buy
+2,237
New +$54K ﹤0.01% 957